These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapeutics of vein graft intimal hyperplasia: 100 years on. Wallitt EJ, Jevon M, Hornick PI. Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453 [Abstract] [Full Text] [Related]
6. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Zimmermann N, Gams E, Hohlfeld T. Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350 [Abstract] [Full Text] [Related]
7. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D. Z Kardiol; 2003 Jul; 92(Suppl 3):III42-7. PubMed ID: 14663601 [Abstract] [Full Text] [Related]
15. Flow dynamics of the St Jude Medical Symmetry aortic connector vein graft anastomosis do not contribute to the risk of acute thrombosis. Redaelli A, Maisano F, Ligorio G, Cattaneo E, Montevecchi FM, Alfieri O. J Thorac Cardiovasc Surg; 2004 Jul; 128(1):117-23. PubMed ID: 15224030 [Abstract] [Full Text] [Related]
16. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Desai ND, Naylor CD, Kiss A, Cohen EA, Feder-Elituv R, Miwa S, Radhakrishnan S, Dubbin J, Schwartz L, Fremes SE, Radial Artery Patency Study Investigators. Circulation; 2007 Feb 13; 115(6):684-91. PubMed ID: 17283268 [Abstract] [Full Text] [Related]